Los Angeles Capital Management LLC Adverum Biotechnologies, Inc. Transaction History

Los Angeles Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$3.36 - $10.56 $71,836 - $225,772	-21,380 Closed	0 $0
Q1 2021 May 05, 2021	SELL	$9.26 - $14.36 $170,865 - $264,970	-18,452 Reduced 46.32%	21,380 $210,000
Q4 2020 Feb 04, 2021	SELL	$9.84 - $14.26 $14,169 - $20,534	-1,440 Reduced 3.49%	39,832 $432,000
Q3 2020 Nov 02, 2020	SELL	$10.3 - $21.64 $107,635 - $226,138	-10,450 Reduced 20.2%	41,272 $425,000
Q2 2020 Aug 05, 2020	BUY	$8.53 - $25.64 $237,176 - $712,920	27,805 Added 116.26%	51,722 $1.08 Million
Q1 2020 May 04, 2020	BUY	$7.98 - $16.32 $190,857 - $390,325	23,917 New	23,917 $234,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.